AzTrials
AzTrials

Spinal Cord InjuriesNCT03517787

The Effect of FES and Therapeutic Exercise on SCI Patients Skeletal Muscles, Sitting Balance, Posture and Quality of Life

A study testing FES+TE, TE and REF-FES+TE in people with Spinal Cord Injuries, run by Tartu University Hospital at 1 site in Estonia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim of the current study is to evaluate the effect functional electrical stimulation and therapeutic exercise on traumatic spinal cord injured participants'skeletal muscle characteristics, sitting balance, lung function and quality of life. Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Spinal Cord Injuries
What is being tested?
FES+TE, TE and REF-FES+TE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
5 participants
Where
1 siteEstonia
Study dates
3 Mar 2017to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Chronic spinal cord injury (12 months post injury) Injury in cervical region resulting in tetraparesis Able to sit on a custom made chair without support Does not have any contraindications for functional electrical stimulation

Trial locations and contacts

1 site in 1 country.

Estonia1 site
  • University of Tartu

    Tartu

Other trials in Estonia

About this study

Official title: The Effect of Functional Electrical Stimulation and Therapeutic Exercise on Functional Properties of Skeletal Muscles, Sitting Postural Stability and Quality of Life in Traumatic Spinal Cord Injury Patients

Aim of the current study is to evaluate the effect functional electrical stimulation and therapeutic exercise on traumatic spinal cord injured participants'skeletal muscle characteristics, sitting balance, lung function and quality of life.

Being tested
FES+TE, TE, REF-FES+TE, REF-TE
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FES+TEOther

    Group receive FES+therapeutic exercise during 6 weeks (twice a week). Altogether 8 exercises are conducted, each done 3 sets and 12 repetitions during first three weeks and 4 sets during last three weeks of intervention).

  • TEOther

    Group perform only therapeutic exercise. Exercises are the same between all 4 groups.

  • REF-FES+TEOther

    Group perform FES+TE, but only participate in 1 session to collect reference data.

  • REF-TEOther

    Group perform only therapeutic exercise, but only participate in 1 session to collect reference data.

Study groups in NCT03517787
Study groupRoleWhat they receive
FES+TEExperimentalParticipants receiving Functional electrical stimulation (FES) combined with therapeutic exercise (TE)
Receives: Other: FES+TE
TEActive comparatorParticipants receiving only therapeutic exercise
Receives: Other: TE
REF-FES+TEOtherHealthy adults (reference group REF) that participate only in 1 session and receive FES and therapeutic exercise
Receives: Other: REF-FES+TE
REF-TEOtherHealthy adults that participate only in 1 session and receive only therapeutic exercise
Receives: Other: REF-TE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of median power frequency (MPF) and amplitude (A)

    Change of MPF and A is measured after first therapy to assess the baseline values and then after 6 weeks of therapy to assess the effectiveness of intervention.

    Measured: Change from baseline measure at 6 weeks

Secondary outcomes (1)
  1. Change of muscle tone

    Muscle oscillation frequency (MOF) is measured to assess muscle tone. Change of MOF is measured after first therapy to assess the baseline values and then after 6 weeks of therapy to assess the effectiveness of intervention.

    Measured: Change from baseline measure at 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2018
  2. Study start3 Mar 2017
  3. Primary completion31 Dec 2018
  4. Study completion31 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
5 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03517787
Sponsor's protocol ID
Spinaal
Status last verified
Dec 2023
First submitted
10 Apr 2018
Last updated
14 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing FES+TE, TE and REF-FES+TE in people with Spinal Cord Injuries, run by Tartu University Hospital at 1 site in Estonia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Estonia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of median power frequency (MPF) and amplitude (A) (time frame: Change from baseline measure at 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in